Consumer Retailing Healthcare Sector

TherapeuticsMD

Market Cap: US$16.8m

Operates as a pharmaceutical royalty company in the United States.

VYNE Therapeutics

Market Cap: US$16.7m

A clinical-stage biopharmaceutical company, focuses on developing therapies to treat chronic inflammatory and immune-mediated conditions.

MedX Health

Market Cap: CA$22.9m

Develops, manufactures, and markets skin related screening tools and phototherapy devices for pain relief and tissue repair in Canada, the United States, Europe, and internationally.

Beyond Air

Market Cap: US$16.6m

A commercial-stage medical device and biopharmaceutical company, develops the Lungfit platform, a nitric oxide (NO) generator and delivery system platform.

IRIDEX

Market Cap: US$16.6m

An ophthalmic medical technology company, provides therapeutic based laser systems, delivery devices, and consumable instrumentation to treat sight-threatening eye diseases in ophthalmology.

Poolbeg Pharma

Market Cap: UK£12.3m

Operates as a biopharmaceutical company, engages in the development and commercialization of medicines for unmet medical needs in the United Kingdom.

ProMIS Neurosciences

Market Cap: US$16.5m

ProMIS Neurosciences, Inc. discovers and develops antibody therapies and therapeutic vaccines for neurodegenerative diseases and other misfolded protein diseases in Canada.

Unidoc Health

Market Cap: CA$22.5m

Operates as a healthcare services company in Canada.

PharmChem

Market Cap: US$16.3m

Provides PharmChek Sweat Patch that is used to detect drugs of abuse.

Ludwig Enterprises

Market Cap: US$16.2m

Operates as a genomic technology and health related company in the United States.

Allarity Therapeutics

Market Cap: US$16.1m

A clinical-stage precision medicine pharmaceutical company, focuses on developing novel anti-cancer therapeutics for patients with unmet medical needs.

GlycoMimetics

Market Cap: US$16.0m

Engages in the discovery and development of therapies for cancers and inflammatory diseases in the United States.

Next Science

Market Cap: AU$24.5m

Engages in the research, development, and commercialization of technologies that resolve the issues in human health caused by biofilms, incumbent bacteria, fungus, viruses, and infections in North America, Australia, and New Zealand.

Neurotech International

Market Cap: AU$24.1m

A clinical-stage biopharmaceutical development company, engages in the research, design, development, and manufacture of medical devices and solutions in Australia.

DH Enchantment

Market Cap: US$15.3m

Through its subsidiary, Ho Shun Yi Limited, engages in the sale and distribution of COVID-19 rapid antigen tester sets in Hong Kong.

Leap Therapeutics

Market Cap: US$15.2m

A biopharmaceutical company, acquires and develops antibody therapies for the treatment of cancer.

EMV Capital

Market Cap: UK£11.2m

A venture capital firm specializing in seed, growth capital, early and mid stage investments.

Avem Health Partners

Market Cap: US$15.2m

Provides financial, technology, management, and capital solutions to hospitals in rural markets.

American Shared Hospital Services

Market Cap: US$15.2m

Provides technology solutions for stereotactic radiosurgery and advanced radiation therapy equipment and services.

Exlites Holdings International

Market Cap: US$15.0m

Manufactures and distributes medical products.

Calidi Biotherapeutics

Market Cap: US$15.0m

A clinical stage immuno-oncology company, develops allogeneic stem cell-based and enveloped virus platforms to potentiate and deliver oncolytic viruses in the United States.

Izotropic

Market Cap: CA$20.6m

A research and development company, develops diagnostic products for detecting breast cancers.

Cocrystal Pharma

Market Cap: US$14.9m

A biotechnology company, focuses on the discovery and development of antiviral therapeutic treatments for serious and/or chronic viral diseases in the United States.

Advanced Health Intelligence

Market Cap: AU$22.6m

Operates as a mobile application and technology development company in Australia and internationally.

Precipio

Market Cap: US$14.7m

A healthcare biotechnology company, provides cancer diagnostic products, reagents, and services in the United States.

MEI Pharma

Market Cap: US$14.7m

A clinical-stage pharmaceutical company, focuses on the development of various therapies for the treatment of cancer.

Harvard Bioscience

Market Cap: US$14.6m

Develops, manufactures, and sells technologies, products, and services for life science applications in the United States, Germany, and internationally.

ProBiotix Health

Market Cap: UK£10.7m

Develops probiotics to tackle cardiovascular disease and other lifestyle conditions in the United Kingdom, the United States, and internationally.

Charlotte's Web Holdings

Market Cap: CA$19.8m

Engages in the farming, manufacturing, marketing, and sale of hemp-derived cannabidiol (CBD) and other botanical-based wellness products.

Curative Biotechnology

Market Cap: US$14.4m

A development-stage biomedical company, develops, licenses, and commercializes pharmaceutical products and medical devices.

IXICO

Market Cap: UK£10.7m

Provides data analytics services to the biopharmaceutical industry in the United Kingdom, Switzerland, the Netherlands, Ireland, rest of Europe, and the United States.

PreveCeutical Medical

Market Cap: CA$19.8m

A health sciences company, engages in the development of options for preventive and curative therapies utilizing organic and nature identical products.

Ernexa Therapeutics

Market Cap: US$14.2m

A preclinical-stage company, develops induces derived mesenchymal stem cells (iMSC) therapies for the treatment of solid tumors and autoimmune disease.

Equillium

Market Cap: US$14.1m

A clinical-stage biotechnology company, develops therapeutics to treat severe autoimmune and inflammatory, or immuno-inflammatory disorders with unmet medical need in the United States.

GeoVax Labs

Market Cap: US$14.1m

A clinical-stage biotechnology company, develops human vaccines and immunotherapies against infectious diseases and solid tumor cancers using novel proprietary platforms in the United States.

Edesa Biotech

Market Cap: US$14.1m

A clinical-stage biopharmaceutical company, engages in the research and development, manufacture, and commercialization of pharmaceutical products for inflammatory and immune-related diseases.